StockSelector.com
  Research, Select, & Monitor Sunday, August 25, 2019 4:08:53 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Amneal Pharmaceuticals, Inc.$2.52($.16)(5.97%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Amneal Pharmaceuticals, Inc. has an overall rank of 814 out of 7130 stocks based on 15 positive rankings and 9 negative rankings.

Positive Rankings
Top Intrinsic Values
Amneal Pharmaceuticals rank is 53
Target Prices
The average analysts' target price is $6.67 for Amneal Pharmaceuticals using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Amneal Pharmaceuticals is ranked 59.
PEGValue
Amneal Pharmaceuticals has a PEG Value of $13.92. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 452.38% in the next year. Among companies with a PEG Value above the current stock price, Amneal Pharmaceuticals is ranked 120.
Low Put/Call
Amneal Pharmaceuticals has a low Put/Call ratio of 0.09 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Amneal Pharmaceuticals is ranked 246.
Price-to-Sales
Amneal Pharmaceuticals rank is 316
SSValue
The StockSelector Value for Amneal Pharmaceuticals is $9.70. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Amneal Pharmaceuticals is ranked 322.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Amneal Pharmaceuticals is ranked 332.
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Amneal Pharmaceuticals is ranked 375.
Historic Revenue Growth
Amneal Pharmaceuticals rank is 481
Low vPut/Call
Amneal Pharmaceuticals has a low Put/Call ratio of 0.26 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Amneal Pharmaceuticals is ranked 523.
Price-to-Book
Amneal Pharmaceuticals rank is 999
Highest Net Margin
Amneal Pharmaceuticals rank is 1492
Historic EPS Growth
Amneal Pharmaceuticals rank is 1697
Oversold Stochastics
Amneal Pharmaceuticals rank is 1742
Estimated Revenue Growth
Amneal Pharmaceuticals rank is 2100
Negative Rankings
90 Day Loss
Amneal Pharmaceuticals rank is 47
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (14.86%). Among companies that have had their estimates lowerec within the past month, Amneal Pharmaceuticals is ranked 231.
Negative EPS Growth
Amneal Pharmaceuticals rank is 267
10 Day Loss
Amneal Pharmaceuticals rank is 475
Negative Cash Growth
Amneal Pharmaceuticals rank is 579
Debt-to-Equity
Amneal Pharmaceuticals rank is 969
Negative ROE
Amneal Pharmaceuticals rank is 992
Down EPS Surprise
Amneal Pharmaceuticals missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROA
Amneal Pharmaceuticals rank is 1472







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.